| Sources | Names Used |
|---|---|
| CTRPv2 | compound 1B |
| PharmacoGx | compound 1B |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PCDHB12 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | CCNB3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | C16orf70 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | FLNA | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | EIF3F | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | USF1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | ARHGEF40 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | PGAM4 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | TBL3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | CHPT1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
